Your session is about to expire
← Back to Search
ActivSight Imaging for Esophageal Surgery
N/A
Recruiting
Research Sponsored by Activ Surgical
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 28 days
Awards & highlights
No Placebo-Only Group
Summary
This trial uses a device that creates a visual representation of blood flow and tissue perfusion during laparoscopic surgery. It will compare accuracy of the device to naked eye inspection and other imaging techniques.
Who is the study for?
This trial is for adults over 18 who need laparoscopic esophageal surgery. They must be able to understand the study, have normal organ function, and not suffer from severe breathing issues. People with allergies to ICG or iodides, pregnant women, those on certain drugs, or with chronic kidney problems can't join.
What is being tested?
The ActivSight™ system is being tested during esophageal surgeries to see if it helps surgeons better visualize blood flow and tissue health compared to traditional methods like naked eye inspection or other imaging techniques.
What are the potential side effects?
Since ActivSight™ is a visualization tool used during surgery rather than a drug, it doesn't have typical side effects. However, there may be risks associated with its use in surgery that will be monitored.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 28 days
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~28 days
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Episodes of intraoperative decision change based on display
Incidence of Adverse Events in 28 days following use of ActivSight™
Latency of display of ActivSight™.
+7 moreSecondary study objectives
Blood Vessel
Ability of ActivSightTM to display perfusion.
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
1Treatment groups
Experimental Treatment
Group I: ActivSight GroupExperimental Treatment1 Intervention
Patients undergoing esophagectomy with ActivSight (n=70)
Find a Location
Who is running the clinical trial?
West Penn Allegheny Health SystemOTHER
35 Previous Clinical Trials
5,939 Total Patients Enrolled
Activ SurgicalLead Sponsor
3 Previous Clinical Trials
187 Total Patients Enrolled
University of Pittsburgh Medical CenterOTHER
75 Previous Clinical Trials
76,873 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I don't have trouble breathing at rest and my oxygen level is above 94% without assistance.I do not have chronic kidney issues, allergies to ICG or iodides, and am not pregnant or breastfeeding.I need surgery for a suspected bowel lesion.My platelet count is at least 75,000, even if I've had transfusions.My kidney function is within the normal range according to my age.I have had surgery before.My cancer involves areas needing surgical connection in my digestive tract.I am over 18 and will have surgery to remove part of my esophagus.
Research Study Groups:
This trial has the following groups:- Group 1: ActivSight Group
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.